{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T05:24:23Z","timestamp":1733808263344,"version":"3.30.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"21-22","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["MMW Fortschr Med"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s15006-024-4301-9","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T23:04:54Z","timestamp":1733785494000},"page":"60-66","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Akute Haut- und  Weichgewebeinfektionen","Management and antibiotic therapy of acute skin and soft tissue infections"],"prefix":"10.1007","volume":"166","author":[{"given":"Birgitt","family":"Mergen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Seybold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,10]]},"reference":[{"key":"4301_CR5972","unstructured":"Sunderk\u00f6tter C et al. Calculated initial parenteral treatment of bacterial infections: Skin and soft tissue infections. GMS Infect Dis. 2020;8:Doc11"},{"key":"4301_CR5976","doi-asserted-by":"crossref","unstructured":"Engel C et al. Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med. 2007.;33:606\u221218","DOI":"10.1007\/s00134-006-0517-7"},{"key":"4301_CR5980","doi-asserted-by":"crossref","unstructured":"Sunderk\u00f6tter C et al. S2k-Leitlinie Haut- und Weichgewebeinfektionen. Auszug aus Kalkulierte parenterale Initialtherapie bakterieller Erkrankungen bei Erwachsenen - Update 2018. J Dtsch Dermatol Ges. 2019;17:345\u221271","DOI":"10.1111\/ddg.13790_g"},{"key":"4301_CR5984","doi-asserted-by":"crossref","unstructured":"Stevens DL et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis. 2014;59:147\u221259","DOI":"10.1093\/cid\/ciu444"},{"key":"4301_CR5988","doi-asserted-by":"crossref","unstructured":"Sunderk\u00f6tter C, Michl C. Praktikabilit\u00e4t der Leitlinie zu Haut- und Weichgewebeinfektionen [Practicability of the German guidelines on skin and soft tissue infections]. Dermatologie (Heidelb). 2023;74:858\u221263","DOI":"10.1007\/s00105-023-05229-z"},{"key":"4301_CR5992","doi-asserted-by":"crossref","unstructured":"Sartelli M et al. 2018 WSES\/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections. World J Emerg Surg. 2018;13:58","DOI":"10.1186\/s13017-018-0219-9"},{"key":"4301_CR6002","doi-asserted-by":"crossref","unstructured":"Fabri M. Kutane Infektionen durch Staphylokokken und Streptokokken. hautnah dermatologie. 2021;37(Suppl 1):34-42","DOI":"10.1007\/s15012-020-6595-3"},{"key":"4301_CR6020","doi-asserted-by":"crossref","unstructured":"Raff AB, Kroshinsky D. Cellulitis: A Review. JAMA. 2016;316:325\u221237","DOI":"10.1001\/jama.2016.8825"},{"key":"4301_CR6032","doi-asserted-by":"crossref","unstructured":"Misiakos EP et al. Current concepts in the management of necrotizing fasciitis. Front Surg. 2014;1:36","DOI":"10.3389\/fsurg.2014.00036"},{"key":"4301_CR6038","doi-asserted-by":"crossref","unstructured":"Eckmann C, Montravers P. Current management of necrotizing soft-tissue infections. Curr Opin Infect Dis. 2021;34:89\u221295","DOI":"10.1097\/QCO.0000000000000700"}],"container-title":["MMW - Fortschritte der Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-024-4301-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15006-024-4301-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-024-4301-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:04:54Z","timestamp":1733789094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.springermedizin.de\/doi\/10.1007\/s15006-024-4301-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":10,"journal-issue":{"issue":"21-22","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["4301"],"URL":"https:\/\/doi.org\/10.1007\/s15006-024-4301-9","relation":{},"ISSN":["1438-3276","1613-3560"],"issn-type":[{"type":"print","value":"1438-3276"},{"type":"electronic","value":"1613-3560"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"10 December 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Die Autorin und der Autor erkl\u00e4ren, dass sie sich bei der Erstellung des Beitrages von keinen wirtschaftlichen Interessen leiten lie\u00dfen. Sie legen folgende potenzielle Interessenkonflikte offen: keine.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Der Verlag erkl\u00e4rt, dass die inhaltliche Qualit\u00e4t des Beitrags durch zwei unabh\u00e4ngige Gutachten best\u00e4tigt wurde. Werbung in dieser Zeitschriftenausgabe hat keinen Bezug zur CME-Fortbildung.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Der Verlag garantiert, dass die CME-Fortbildung sowie die CME-Fragen frei sind von werblichen Aussagen und keinerlei Produktempfehlungen enthalten. Dies gilt insbesondere f\u00fcr Pr\u00e4parate, die zur Therapie des dargestellten Krankheitsbildes geeignet sind.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}